The "Etanercept - Biosimilar Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This "Etanercept - Biosimilar Insight, 2024" report provides comprehensive insights about 15+ ...

CN Energy Group. Inc. (the "Company"; NASDAQ: CNEY), today announced that on September 6, 2024, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ...

The stock made the NASDAQ top percentage gainer list on big volume today, with no news from the company as a source. The retail investor driven stock is currently trading at $1.1500, up 0.8699, ...

The main goal of this report is to “determine the influence of pesticide contamination on the microbial population, ...

In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...